Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ocular Therapeutix (OCUL) Gross Profit: 2012-2024

Historic Gross Profit for Ocular Therapeutix (OCUL) over the last 13 years, with Dec 2024 value amounting to $22.1 million.

  • Ocular Therapeutix's Gross Profit fell 69.99% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 million, marking a year-over-year decrease of 81.45%. This contributed to the annual value of $22.1 million for FY2024, which is 23.69% up from last year.
  • Ocular Therapeutix's Gross Profit amounted to $22.1 million in FY2024, which was up 23.69% from $17.9 million recorded in FY2023.
  • In the past 5 years, Ocular Therapeutix's Gross Profit ranged from a high of $22.1 million in FY2024 and a low of -$9.2 million during FY2020.
  • Over the past 3 years, Ocular Therapeutix's median Gross Profit value was $17.9 million (recorded in 2023), while the average stood at $17.2 million.
  • Data for Ocular Therapeutix's Gross Profit shows a peak YoY spiked of 190.46% (in 2021) over the last 5 years.
  • Ocular Therapeutix's Gross Profit (Yearly) stood at -$9.2 million in 2020, then surged by 190.46% to $8.3 million in 2021, then soared by 38.89% to $11.6 million in 2022, then spiked by 54.63% to $17.9 million in 2023, then grew by 23.69% to $22.1 million in 2024.